When should I stop anticoagulation for atrial fibrillation?

Greiver, Michelle
May 2005
CMAJ: Canadian Medical Association Journal;5/24/2005, Vol. 172 Issue 11, p1437
Academic Journal
Provides the case of a practising community family physician who relied on anticoagulation for atrial fibrillation. Adverse effect of anticoagulation; Risk of a stroke for patients taking warfarin for atrial fibrillation; Limitations of the approach used by the physician.


Related Articles

  • WHAT I WILL DO NOW. Griffith, Kathryn // Pulse;11/26/2008, Vol. 68 Issue 41, p35 

    The article offers information related to the usage of warfarin. According to th author, warfare is underused for stroke prevention in Atrial fibrillation (AF) and it is important to reassess each patients risk of stroke, probably on an annual basis. She notes that the CHADS2 appears a...

  • High-dose warfarin reduces mortality rates in AF patients.  // GP: General Practitioner;9/22/2003, p14 

    High-dose warfarin not only reduces the risk of stroke, it also significantly lowers mortality rates and improves the outcome following stroke in patients with atrial fibrillation (AF), according to a large U.S. study. The study included data from 13,559 patients with AF. Patients given...

  • Stroke in AF. Nichols, Emma Hitt; Lip, Gregory Y. H.; Camm, A. John; Whitlock, Richard // MD Conference Express;Jun2015, Vol. 15 Issue 12, p15 

    Patients with atrial fibrillation are at increased risk of stroke, and the addition of a single risk factor indicates a need for prophylaxis with warfarin or a non-VKA oral anticoagulant. Left atrial appendage occlusion is a potential alternative if long-term anticoagulation is contraindicated.

  • Anticoagulation rates inadequate in elderly women with AF.  // Geriatrics;Apr2006, Vol. 61 Issue 4, p17 

    Discusses a restrospective study which revealed that elderly patients, especially elderly women with atrial fibrillation have low rates of anticoagulation. Participants of the study including elderly women who are at especially high risk of stroke; Comparison between warfarin use among the...

  • Anticoagulation Risks in Atrial Fibrillation. Zepf, Bill // American Family Physician;4/1/2004, Vol. 69 Issue 7, p1792 

    Discusses research being done on the relationship between anticoagulation intensity and stroke frequency, severity and mortality in patients with atrial fibrillation. Reference to a study by E.M. Hylek and colleagues, published in the September 11, 2003 issue of "New England Journal of...

  • The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation. Ezekowitz, Michael D.; Falk, Rodney H. // Mayo Clinic Proceedings;Jul2004, Vol. 79 Issue 7, p904 

    Ischemic stroke, a major complication of atrial fibrillation (AF), is believed to result from atrial thrombus formation caused by ineffective atrial contraction. Oral anticoagulant therapy effectively reduces the risk of ischemic stroke in patients with AF, this therapy is recommended for...

  • Dabigatran: An Oral Direct Thrombin Inhibitor.  // Travel Medicine Advisor;Feb2010 Supplement, p1 

    The article focuses on the study concerning the use of dabigatran in treating patients with acute venous thromboembolism. It says that dabigatran is an oral direct thrombin inhibitor which is used by many countries as an alternative to warfarin. Moreover, the drug has shown to be as effective as...

  • Bleeds discourage use of warfarin.  // Pulse;1/19/2006, Vol. 66 Issue 3, p18 

    The article reports on a study showing that physicians prescribe warfarin less often after having a stroke patient who has suffered an anticoagulation-related bleed. The research was led by Niteesh Choudhry, instructor in medicine at Harvard Medical School. The research team warned that as the...

  • Warfarin Not of Benefit to All?  // Clinician Reviews;Nov2009, Vol. 19 Issue 11, p16 

    The article discusses the net clinical benefit of warfarin therapy. It cites a report that this therapy appears to be the greatest in atrial fibrillation patients aged 85 years old and above and those who had suffered a stroke. These results could be a basis to reconsider the benefits of using...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics